Phillip J. Stella

Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2

D. L. Barton, H. Liu, S. R. Dakhil et al. · JNCI Journal of the National Cancer Institute · 2013 · 297 citations · Full text

Medicine, Oncology, Pharmacology +2

Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes

Charles L. Loprinzi, Jeff A. Sloan, Edith A. Perez et al. · Journal of Clinical Oncology · 2002 · 265 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

G. Bodoky, Constanta Timcheva, David R. Spigel et al. · Investigational New Drugs · 2011 · 230 citations

Medicine, Oncology, Pharmacology +13

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Noah Kornblum, Fengmin Zhao, Judith Manola et al. · Journal of Clinical Oncology · 2018 · 189 citations · Full text

Medicine, Oncology, Pharmacology +16

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

John D. Hainsworth, C. Cebotaru, Vladimir Kanarev et al. · Journal of Thoracic Oncology · 2010 · 160 citations · Full text

Medicine, Oncology, Pharmacology +11